Featured below are companies that have experienced recent insider trading activity in the public market through their direct and indirect ownerships, including accounts they have control or direction over.
The list features insider transaction activity; it does not convey total ownership information as an insider may hold numerous accounts.
Keep in mind, when looking at transaction activities by insiders, purchasing activity may reflect perceived value in a security. Selling activity may or may not be related to a stock’s valuation; perhaps an insider needs to raise money for personal reasons. An insider’s total holdings should be considered because a sale may, in context, be insignificant if this person has a large remaining position in the company. I tend to put great weight on insider transaction activity when I see multiple insiders trading a company’s shares or units.
Let's begin the report featuring a security that has had recent insider buying activity.
Diversified Royalty Corp. (DIV-T)
On Sept. 7, Johnny Ciampi, who sits on the board of directors, acquired 20,000 shares at a cost per share of $3.22 for an account in which he has indirect ownership (Lucris Capital Corp.), lifting the account’s holdings to 606,538 shares.
On Sept. 6, fellow board member Lorraine McLachlan bought 3,500 shares at a price per share of $3.20, initiating a portfolio position.
=====
The following four stocks have had recent selling activity reported by insiders.
CannTrust Holdings Inc. (TRST-T)
On Sept. 13, chairman Mark Litwin sold 10,000 shares in this cannabis company at a price per share of $11.397. On Aug. 24, he sold 20,000 shares at a price per share of $9.2433. After these transactions, his account held 10,000 shares.
HEXO Corp. (HEXO-T)
Two insiders reported recent sales in this marijuana stock.
On Sept. 12, chair Dr. Michael Munzar sold 10,000 shares in his personal account at a price per share of $8.8316, reducing his portfolio’s position to 140,000 shares. Days prior, on Sept. 7., Dr. Munzar sold 162,000 shares at a price per share of $7.7459 for an account in which he has indirect ownership (159927 Canada Inc.), lowering the account’s holdings to 1,710,866 shares.
On Sept. 7, Dr. Terry Lake, vice-president of corporate and social responsibility, sold 1,500 shares at a price per share of $7.65, leaving 4,000 shares remaining in his account.
New Look Vision Group Inc. (BCI-T)
On Sept. 6, Marie-Josée Mercier, vice-president – sales and customer experience at New Look Eyewear, sold 1,620 shares at a price per share of $34.39, lowering her account balance to 11,215 shares.
On Sept. 5, senior vice-president of optician networks and president at New Look Eyewear Mario Pageau divested 1,500 shares at a price per share of $34.15, reducing his portfolio’s holdings to 21,661 shares.
OrganiGram Holdings Inc. (OGI-X)
Between Sept. 7 and Sept.10, Dr. Kenneth Mitton, who sits on the board of directors, sold a total of 100,000 shares of this marijuana company at an average price per share of approximately $7.06, reducing his portfolio’s holdings to 482,860 shares.
Jennifer Dowty